How Much Does DMEPOS Facility Accreditation Really Cost? A Price Comparison

For durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) suppliers, accreditation is not optional if they intend to bill Medicare. Yet the price of achieving and maintaining that status remains one of the least transparent line items in a supplier’s budget. Providers shopping for accreditation often find that the headline fee is only part of the story—application charges, site survey costs, and annual compliance fees can vary substantially depending on the accrediting organization, the size of the operation, and the complexity of the product lines offered.

Recent Trends in Accreditation Pricing

Over the past several years, the market for DMEPOS accreditation has remained concentrated among a small number of nationally recognized accrediting organizations. While these bodies all meet the same Centers for Medicare & Medicaid Services (CMS) standards, their pricing structures have not converged. Some offer flat-rate pricing for standard suppliers, while others use tiered schedules based on annual revenue, number of locations, or the types of items supplied.

Recent market behavior suggests a shift toward bundling. Several accreditations now include the initial survey, one mid-cycle survey or documentation review, and a compliance toolkit in a single package. This bundling makes upfront price comparisons easier but can obscure the cost of corrective-action follow-ups, which are rarely included in the quoted price.

Background: Why Accreditation Exists and Who Pays

Accreditation is a condition of participation for DMEPOS suppliers billing Medicare. The process was designed to verify that suppliers meet quality standards related to beneficiary protections, complaint handling, and proper documentation of orders. It is a third-party review intended to supplement, not replace, state licensure requirements.

The cost structure generally falls into four buckets:

• Application or enrollment fees — paid upfront before the review begins.
• Site survey fees — the largest single expense, covering an on-site inspection of the physical facility and its records.
• Annual fees — ongoing charges to keep accreditation active between survey cycles.
• Corrective action or re-survey fees — charged when deficiencies are found and a follow-up visit is required.

User Concerns: What Suppliers Are Really Asking

When suppliers compare price quotes, the most common questions are not just about the dollar amount but about what triggers additional costs. A low upfront quote can become expensive if the accreditor charges per deficiency cited or per repeated survey attempt. Suppliers also worry about hidden costs tied to business growth—such as adding a new location or expanding into a new product category like complex rehab or oxygen—which may require a separate survey.

Another concern is timing. Most accreditors charge an expedited review fee, which can significantly raise the total cost for a supplier who needs accreditation quickly to secure a Medicare contract. Suppliers should confirm whether the quoted price covers the entire review timeline or only the standard processing window.

Key differences to compare across accreditors:

• Whether the fee covers one site or all sites under the same owner.
• Whether the initial fee includes the first annual renewal or if that is billed separately.
• Whether the accreditor charges for a witness audit as part of the standard cycle.
• Whether there are discounts for multiple years prepaid or multi-location applicants.

Likely Impact: How Cost Differences Affect Supplier Decisions

For a small, single-location supplier, the total cost of accreditation—including application fees, survey, and annual fees—typically falls within a range that most established businesses can absorb as a one-time cost. However, for a supplier operating on thin margins, the difference between the lowest and highest quote can be enough to influence the choice of accreditor, even if that choice is not ideal for the supplier’s long-term service mix.

Larger suppliers with multiple locations face a more complex calculation. Some accreditors cap multi-site fees, while others charge per location. This creates a meaningful gap in total cost for a supplier with five or ten branches. In practice, larger operations tend to select an accreditor based on a combination of cost per site and the ease of coordinating a single survey date across locations.

There is also an indirect cost to consider: the time lost if a site is not ready for survey. A failed initial survey typically triggers a re-survey fee, and the supplier loses weeks of potential Medicare billing eligibility. Comparing prices without comparing the accreditor’s pass/fail history and standards interpretation is therefore incomplete.

What to Watch Next

Suppliers should watch for two converging developments. The first is consolidation among accrediting organizations. If the number of available accreditors shrinks, pricing power may shift, and comparison shopping could become more limited. The second is CMS’s ongoing review of quality standards, which could force accreditors to add new survey elements—such as more detailed audits of telehealth documentation or remote patient monitoring equipment—and pass those costs through to suppliers.

Also on the horizon is the possibility of more frequent validation surveys conducted by CMS or its contractors. These are separate from accreditation surveys and, if they become more common, they replace routine audits with unscheduled inspections in some cases. Suppliers who budget only for accreditation fees may be caught off guard by the added administrative cost of a validation visit.

Finally, watch whether accreditors shift toward risk-based pricing. If an accreditor asks more detailed questions about a supplier’s claim history, returns, or complaint logs before issuing a quote, that may be the first sign that pricing is moving from flat-fee to risk-adjusted—a change that would make direct price comparisons significantly harder in the future.